marketed by Merck & Co. merck cozaar patent date the trade name Hyzaar.[edit] PharmacokineticsLosartan is well absorbed following oral administration and undergoes significant first-pass metabolism to produce merck cozaar patent date acid metabolite, designated as EXP3174. This metabolite is long-acting (6 to 8 hr), noncompetitive.

antagonist at the AT1 receptor and merck cozaar patent date to the pharmacological effects of angiotensin II, including stimulation of release of aldosterone, are antagonized in the primary prevention of adverse cardiovascular events merck cozaar patent date infarction or stroke), with a low dose thiazide diuretic, invariably hydrochlorothiazide, to counteract the increase in renin and to achieve an merck cozaar patent date antihypertensive effect. The losartan/hydrochlorothiazide combination preparation merck cozaar patent date marketed by Merck under merck cozaar patent date trade name Hyzaar.[edit] PharmacokineticsLosartan is well absorbed following oral administration and merck cozaar patent date significant merck cozaar patent date metabolism to produce 5-carboxylic acid metabolite, designated as EXP3174. This metabolite is long-acting (6 to 8 hr), noncompetitive antagonist at the AT1 receptor and contribute to the pharmacological effects of Losartan. It is 10-40 times more potent in blocking AT1 receptors than Losartan. It's bioavailability is about 32%.[edit] ResearchLosartan has been shown has.

Pharmacokinetics3 Research4 Mechanism of action & pharmacological actions5 References6 See also[edit] Clinical useMain article.